Mesa Laboratories, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US59064R1095
USD
77.15
1.09 (1.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1157512,
    "name": "Mesa Laboratories, Inc.",
    "stock_name": "Mesa Laboratories, Inc.",
    "full_name": "Mesa Laboratories, Inc.",
    "name_url": "stocks-analysis/mesa-laboratories-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "77.15",
    "chg": 1.09,
    "chgp": "1.43%",
    "dir": 1,
    "prev_price": "76.06",
    "mcapval": "350.77",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US59064R1095",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "257.33 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mesa-laboratories-inc-1157512-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Mesa Laboratories, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mesa-laboratories-inc-technically-bullish-or-bearish-3545122",
        "imagepath": "",
        "date": "2025-09-20 19:04:09",
        "description": "As of 1 July 2025, the technical trend for Mesa Laboratories, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from multiple indicators: the MACD is bearish on both weekly and monthly time frames, moving averages are bearish on a daily basis, and the KST is bearish across both weekly and monthly periods. Additionally, Bollinger Bands and OBV show mildly bearish signals. The Dow Theory indicates a mildly bearish trend on the weekly chart, while the monthly chart shows no trend.\n\nIn terms of performance, the stock has significantly underperformed against the S&P 500, with a year-to-date return of -47.55% compared to the S&P 500's 12.22%, and a one-year return of -45.17% versus 17.14% for the benchmark...."
      },
      {
        "title": "Is Mesa Laboratories, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mesa-laboratories-inc-overvalued-or-undervalued-3541840",
        "imagepath": "",
        "date": "2025-09-20 17:37:44",
        "description": "As of 5 June 2024, Mesa Laboratories, Inc. has moved from a fair to risky valuation grade. The company appears to be overvalued, particularly given its significant losses reflected in the P/E ratio, which is not applicable due to the loss-making status. Key ratios include a Price to Book Value of 3.55, an EV to EBITDA of 17.66, and an EV to Sales of 2.99, all indicating a high valuation relative to its financial performance.\n\nIn comparison to peers, Mesa Laboratories has a notably high EV to EBITDA ratio compared to Atrion Corp. at 26.22, and a significantly worse P/E ratio than Silk Road Medical, Inc. at -19.76. The company's recent stock performance has been poor, with a year-to-date return of -47.55%, contrasting sharply with the S&P 500's positive return of 12.22% over the same period, further reinforcing the overvaluation narrative...."
      }
    ],
    "total": 7,
    "sid": "1157512",
    "stock_news_url": "https://www.marketsmojo.com/news/mesa-laboratories-inc-1157512"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock newsNews and Views
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available